Chul-Ho Yun

Roles of human liver cytochrome P4502C and 3A enzymes in the 3-hydroxylation of benzo(a)pyrene.

T. Shimada, F. Guengerich, C. Yun, 1992, Cancer research.

Identification of the pharmacogenetic determinants of alfentanil metabolism: cytochrome P-450 3A4. An explanation of the variable elimination clearance.

F. Guengerich, A. Wood, M. Wood, 1992, Anesthesiology.

Purification and characterization of human liver microsomal cytochrome P-450 2A6.

T. Shimada, F. Guengerich, C. Yun, 1991, Molecular pharmacology.

Modification of cytochrome P450 1A2 enzymes by the mechanism-based inactivator 2-ethynylnaphthalene and the photoaffinity label 4-azidobiphenyl.

F. Guengerich, M. Martín, C. Yun, 1992, Biochemistry.

Elucidation of catalytic specificities of human cytochrome P450 and glutathione S-transferase enzymes and relevance to molecular epidemiology.

T. Shimada, F. Guengerich, J. Groopman, 1992, Environmental health perspectives.

Oxidation of the angiotensin II receptor antagonist losartan (DuP 753) in human liver microsomes. Role of cytochrome P4503A(4) in formation of the active metabolite EXP3174.

F. Guengerich, J. K. Rho, C. Yun, 1995, Drug metabolism and disposition: the biological fate of chemicals.